Cargando…
miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway
BACKGROUND: MiRNAs have been reported to induce certain drug resistance in multiple solid tumors via various mechanisms. Our study aimed to investigate whether miRNA-1269b was involved in the chemoresistance and the progression of non-small cell lung cancer (NSCLC). METHODS: MTT and colony formation...
Autores principales: | Yang, Wu, Xiao, Wei, Cai, Zhengrong, Jin, Shidai, Li, Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954839/ https://www.ncbi.nlm.nih.gov/pubmed/32021259 http://dx.doi.org/10.2147/OTT.S225010 |
Ejemplares similares
-
miR-1269a and miR-1269b: Emerging Carcinogenic Genes of the miR-1269 Family
por: Xie, Zijun, et al.
Publicado: (2022) -
The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway
por: Chen, Lu, et al.
Publicado: (2020) -
miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway
por: Liu, Jiangang, et al.
Publicado: (2018) -
Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT
por: Zheng, Zhiming, et al.
Publicado: (2017) -
miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway
por: Xu, Fen, et al.
Publicado: (2020)